Medicare Enrolled
Dr. Charles Popeney, D.O.
Neurology · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Popeney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Popeney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Popeney
Dr. Charles Popeney is a neurology specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Popeney performed 693 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Popeney received a total of $103,124 from 97 pharmaceutical and/or device companies across 1478 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Popeney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 40% volume in TX
$103,124 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗693
Medicare services
Top 40% in TX for neurology
Not available
Unique patients (not deduplicated)
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
419 | $63 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $121 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $93 | $145 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
39 | $74 | $175 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $162 | $450 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
11 | $102 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$103,124
Total received (2018-2024)
Avg $14,732/year across 7 years
Top 6% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
1,478
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,300
2023
$4,417
2022
$20,974
2021
$10,942
2020
$17,820
2019
$23,760
2018
$20,911
Payments by company (2024)
ABBVIE INC.
$612
UCB, Inc.
$353
PFIZER INC.
$270
SK Life Science, Inc.
$267
EMD Serono, Inc.
$253
Lundbeck LLC
$217
Biogen, Inc.
$204
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$196
Neurocrine Biosciences, Inc.
$195
ARGENX US, INC.
$161
Alexion Pharmaceuticals, Inc.
$160
Otsuka America Pharmaceutical, Inc.
$151
Teva Pharmaceuticals USA, Inc.
$142
Lilly USA, LLC
$141
Eisai Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$94
JAZZ PHARMACEUTICALS INC.
$87
ACADIA Pharmaceuticals Inc
$83
Grifols USA, LLC
$74
Celgene Corporation
$72
SCILEX PHARMACEUTICALS INC.
$50
Amneal Pharmaceuticals LLC
$44
Sumitomo Pharma America, Inc.
$43
Novartis Pharmaceuticals Corporation
$38
LivaNova USA, Inc.
$37
Madrigal Pharmaceuticals
$33
Vanda Pharmaceuticals Inc.
$33
Kyowa Kirin, Inc.
$27
AstraZeneca Pharmaceuticals LP
$26
MDD US Operations, LLC
$25
Merz Pharmaceuticals, LLC
$23
Medtronic, Inc.
$22
Supernus Pharmaceuticals, Inc.
$20
HARMONY BIOSCIENCES LLC
$19
CATALYST PHARMACEUTICALS, INC.
$17
Harmony Biosciences Llc
$15
Top 3 companies account for 28.7% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$56,921
Biohaven Pharmaceutical Holding Company Ltd.
$12,438
Biohaven Pharmaceuticals, Inc.
$7,490
Promius Pharma LLC
$5,203
ABBVIE INC.
$1,590
UCB, Inc.
$1,491
Biogen, Inc.
$1,416
Novartis Pharmaceuticals Corporation
$1,375
EMD Serono, Inc.
$946
Genentech USA, Inc.
$880
Alexion Pharmaceuticals, Inc.
$855
SK Life Science, Inc.
$843
PFIZER INC.
$680
ACADIA Pharmaceuticals Inc
$602
GENZYME CORPORATION
$583
Neurocrine Biosciences, Inc.
$484
Grifols USA, LLC
$481
Supernus Pharmaceuticals, Inc.
$414
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$398
Lundbeck LLC
$390
Lilly USA, LLC
$387
Eisai Inc.
$384
Allergan, Inc.
$373
ARGENX US, INC.
$330
Amgen Inc.
$306
AbbVie Inc.
$279
Takeda Pharmaceuticals U.S.A., Inc.
$255
Otsuka America Pharmaceutical, Inc.
$249
Bausch Health US, LLC
$242
Amneal Pharmaceuticals LLC
$237
Avanir Pharmaceuticals, Inc.
$234
Celgene Corporation
$224
Allergan Inc.
$219
IMPEL PHARMACEUTICALS INC.
$203
Sunovion Pharmaceuticals Inc.
$180
Harmony Biosciences LLC
$172
Adamas Pharmaceuticals, Inc.
$163
Banner Life Sciences, LLC
$162
US WorldMeds, LLC
$141
Acorda Therapeutics, Inc
$123
Sumitomo Pharma America, Inc.
$120
Octapharma USA, Inc.
$120
EISAI INC.
$117
Zyla Life Sciences
$111
CSL Behring
$104
Merz North America, Inc.
$101
Upsher-Smith Laboratories LLC
$100
ARBOR PHARMACEUTICALS, INC.
$89
Corium, LLC
$88
JAZZ PHARMACEUTICALS INC.
$87
AstraZeneca Pharmaceuticals LP
$86
GE HEALTHCARE
$82
AQUESTIVE THERAPEUTICS, INC.
$78
GE Healthcare
$78
Mitsubishi Tanabe Pharma America, Inc.
$70
IRONWOOD PHARMACEUTICALS, INC
$66
Janssen Pharmaceuticals, Inc
$63
Abbott Laboratories
$61
Neurelis, Inc.
$56
LivaNova USA, Inc.
$55
Vertical Pharmaceuticals, LLC
$54
Endo Pharmaceuticals Inc.
$53
SCILEX PHARMACEUTICALS INC.
$50
Scilex Pharmaceuticals Inc.
$50
Merck Sharp & Dohme Corporation
$48
Kyowa Kirin, Inc.
$48
Validus Pharmaceuticals LLC
$42
HARMONY BIOSCIENCES LLC
$41
Avion Pharmaceuticals
$39
Catalyst Pharmaceuticals, Inc.
$39
BOSTON SCIENTIFIC CORPORATION
$37
Impax Laboratories, Inc.
$36
Madrigal Pharmaceuticals
$33
Vanda Pharmaceuticals Inc.
$33
Mallinckrodt LLC
$33
Assertio Therapeutics, Inc.
$27
Novo Nordisk Inc
$26
MDD US Operations, LLC
$25
Medtronic USA, Inc.
$24
Merz Pharmaceuticals, LLC
$23
Medtronic, Inc.
$22
Aprecia Pharmaceuticals, LLC
$22
BANNER LIFE SCIENCES, LLC
$22
INTERCEPT PHARMACEUTICALS, INC.
$19
Boston Scientific Corporation
$19
Mylan Pharmaceuticals Inc.
$19
Vertiflex, Inc.
$18
Ironwood Pharmaceuticals, Inc
$17
CATALYST PHARMACEUTICALS, INC.
$17
Egalet US Inc
$16
QOL Medical, LLC
$15
PENTAX of America, Inc.
$15
Harmony Biosciences Llc
$15
Arbor Pharmaceuticals, Inc.
$14
Currax Pharmaceuticals LLC
$14
E.R. Squibb & Sons, L.L.C.
$14
Medtronic MiniMed, Inc.
$12
Top 3 companies account for 74.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · COPAXONE · CREXONT · Cambia · CapsoCam · Confirm Rx · DUOPA · Dayvigo · Dhivy · EMGALITY · ENTYVIO · EPIDIOLEX · EVUSHELD · Equetro · Evrysdi · FIRDAPSE · FREESTYLE LIBRE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · JANUVIA · KESIMPTA · KYNMOBI · LEMTRADA · LINZESS · LORZONE · LYRICA · Leqembi · Linzess · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NASCOBAL · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCALIVA · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · Ongentys · Ozempic · PANZYGA · PERCEPT PC BRAINSENSE · PONVORY · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QVAR · Qelbree · RESMETIROM · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Saxenda · Soliris · Spritam · Sucraid · Superion ISS · TECFIDERA · TROKENDI XR · TRULANCE · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VIBERZI · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XIFAXAN · Xadago · Xembify · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor · iPro2
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
332
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Popeney is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Popeney experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Popeney performed 419 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Popeney receive payments from pharmaceutical companies?
Yes. Dr. Popeney received a total of $103,124 from 97 companies across 1,478 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Popeney's costs compare to other neurologists in Sugar Land?
Dr. Popeney's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Popeney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Sugar Land
Browse neurologists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology